EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world???s leading research and advisory firms for specialized biopharmaceutical issues, finds that in their two latest EU5 reports on rheumatoid arthritis (RA), there have been some changes in the way that biologics are used to treat RA patients in the past year.